Company Monitoring Page for Novartis

latest headlines for company on cafepharma

10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
Tags:
R&D, drug development, Eli Lilly, Novartis, Argenx, Bristol-Myers Squibb, Vir Biotechnolgy, Biogen, GSK, Iovance, Roche
Eli Lilly’s Mirikizumab Hits the Mark in Phase III Study, Bests Cosentyx
BioSpace
Sat, 07/18/20 - 12:17 pm
Tags:
Eli Lilly, psoriasis, mirikizumab, clinical trials, Cosentyx, Novartis
Novartis to provide 'no profit' COVID-19 drugs to low income countries
Reuters
Thu, 07/16/20 - 11:00 am
Tags:
Novartis, Sandoz, non-profits, developing countries, generics
Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry
Forbes
Wed, 07/15/20 - 11:22 pm
Tags:
artificial intelligence, machine learning, pharma industry, drug development, AstraZeneca, Novartis
Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop
Fierce Pharma
Wed, 07/15/20 - 11:17 am
Tags:
Novartis, Entresto, heart failure, cardiologists
Propeller gets green light to bundle its digital health tools with inhalers
MedCity News
Thu, 07/9/20 - 11:05 am
Tags:
Novartis, Propeller Health, Europe, digital health, inhalers, digital therapeutics
Pharma's pandemic response could help attract tech talent, Novartis digital chief says
Fierce Pharma
Tue, 07/7/20 - 08:12 pm
Tags:
pharma industry, pandemic, COVID-19, Novartis
Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectables
Fierce Pharma
Tue, 07/7/20 - 08:05 pm
Tags:
Novartis, non-profits, Civica Rx, drug shortages, pandemic, COVID-19
Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism
Fierce Pharma
Thu, 07/2/20 - 11:33 pm
Tags:
racism, pharma advertising, Pfizer, Novartis, AbbVie
Novartis to pay $678M to settle claims over 'sham' doctor events
BioPharma Dive
Thu, 07/2/20 - 11:39 am
Tags:
Novartis, physicians, legal, kickbacks
Amgen's Enbrel Patents to Be Upheld Through 2029
Motley Fool
Thu, 07/2/20 - 12:15 am
Tags:
psoriasis, rheumatoid arthritis, Enbrel, Novartis, biosimilars, patents
Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies
Fierce Pharma
Wed, 07/1/20 - 11:17 am
Tags:
Novartis, Lutathera, radiotherapy, drug manufacturing
Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra
Endpoints
Mon, 06/29/20 - 10:26 am
Tags:
Takeda, Novartis, Xiidra, Europe, EMA, dry eye disease
'No presents anymore': Inside Novartis' scheme to boost Lucentis sales in Greece
Fierce Pharma
Fri, 06/26/20 - 01:08 pm
Tags:
Novartis, Greece, DOJ, Lucentis, kickbacks, physicians
Novartis strikes out with dry eye med Xiidra in Europe
Seeking Alpha
Fri, 06/26/20 - 09:52 am
Tags:
Novartis, dry eye disease, Europe, Xiidra, CHMP
Novartis inks settlements worth $347M with DOJ, SEC over foreign doctor payments, records keeping
Fierce Pharma
Thu, 06/25/20 - 08:39 pm
Tags:
Novartis, DOJ, kickbacks, physicians, FCPA, SEC
With cell and gene therapy boom coming, experts at Novartis, Kite trumpet need for capacity: panel
Fierce Pharma
Wed, 06/24/20 - 11:21 pm
Tags:
cell therapy, gene therapy, Novartis, Kite Pharma, Biomarin, Astellas
Novartis Shuts Down Hydroxychloroquine COVID-19 Clinical Trial
Motley Fool
Mon, 06/22/20 - 08:40 pm
Tags:
Novartis, clinical trials, hydroxychloroquine, COVID-19, pandemic
Novartis gets FDA approval for Cosentyx to treat active non-radiographic axial spondyloarthritis
Pharmaceutical Business Review
Thu, 06/18/20 - 10:32 am
Tags:
Novartis, Cosentyx, non-radiographic axial spondyloarthritis
Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis
Fierce Pharma
Wed, 06/17/20 - 09:57 am
Tags:
Novartis, Eli Lilly, Cosentyx, Taltz, spondyloarthritis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.